, Volume 215, Issue 2, pp 257–266 | Cite as

Pharmacological characterization of social isolation-induced hyperactivity

  • Katrine Fabricius
  • Lone Helboe
  • Anders Fink-Jensen
  • Gitta Wörtwein
  • Björn Steiniger-Brach
Original Investigation



Social isolation (SI) of rats directly after weaning is a non-pharmacological, non-lesion animal model based on the neurodevelopmental hypothesis of schizophrenia. The model causes several neurobiological and behavioral alterations consistent with observations in schizophrenia.


In the present study, we evaluated if isolated rats display both a pre-pulse inhibition (PPI) deficit and hyperactivity. Furthermore, the sensitivity of SI hyperactivity to antipsychotic was evaluated.


Rats were socially isolated or group-housed for 12 weeks starting on postnatal day 25. In one batch of animals, the PPI and hyperactivity response were repeatedly compared. Furthermore, we investigated the robustness of the SI-induced hyperactivity by testing close to 50 batches of socially isolated or group-housed rats and tested the sensitivity of the assay to first- and second-generation antipsychotics, haloperidol, olanzapine, and risperidone, as well as the group II selective metabotrobic glutamate receptor agonist (LY404039).


Socially isolated rats showed a minor PPI deficit and a robust increase in hyperactivity compared with controls. Furthermore, SI-induced hyperactivity was selectively reversed by all antipsychotics, as well as the potential new antipsychotic, LY404039.


SI-induced hyperactivity was more pronounced and robust, as compared with SI-induced PPI deficits. Furthermore, SI-induced hyperactivity might be predictive for antipsychotic efficacy, as current treatment was effective in the model. Finally, using LY404039, a compound in development against schizophrenia, we have shown that the hyperactivity assay is sensitive to potential novel mechanisms of action. Thus, SI-induced hyperactivity might be a robust and novel in vivo screening assay of antipsychotic efficacy.


Social isolation Hyperactivity Pre-pulse inhibition Antipsychotic Metabotrobic glutamate receptor mGLUR Schizophrenia 



We sincerely thank technician Ditte Bekker-Jensen and senior technician Vibeke Nielsen H. Lundbeck A/S, Department of In Vivo Neuropharmacology, for performing the locomotor activity studies on the repeated tested cohort and performing the PPI study.


The work presented is part of a PhD work funded by the Neurocluster scholarship at the Faculty of Health and Science, University of Copenhagen, Denmark.


  1. Abdul-Monim Z, Reynolds GP, Neill JC (2003) The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacol 17:57–65PubMedCrossRefGoogle Scholar
  2. Arnt J (1982) Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol (Copenh) 51:321–329CrossRefGoogle Scholar
  3. Arnt J (1995) Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of d-amphetamine. Eur J Pharmacol 283:55–62PubMedCrossRefGoogle Scholar
  4. Arnt J, Skarsfeldt T (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63–101PubMedCrossRefGoogle Scholar
  5. Bakshi VP, Geyer MA (1999) Ontogeny of isolation rearing-induced deficits in sensorimotor gating in rats. Physiol Behav 67:385–392PubMedCrossRefGoogle Scholar
  6. Bakshi VP, Swerdlow NR, Braff DL, Geyer MA (1998) Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Biol Psychiatry 43:436–445PubMedCrossRefGoogle Scholar
  7. Bianchi M, Fone KF, Azmi N, Heidbreder CA, Hagan JJ, Marsden CA (2006) Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. Eur J Neurosci 24:2894–2902PubMedCrossRefGoogle Scholar
  8. Cartmell J, Monn JA, Schoepp DD (1999) The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 291:161–170PubMedGoogle Scholar
  9. Cilia J, Reavill C, Hagan JJ, Jones DN (2001) Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats. Psychopharmacology (Berl) 156:327–337CrossRefGoogle Scholar
  10. Cilia J, Hatcher PD, Reavill C, Jones DN (2005) Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats: an update. Psychopharmacology (Berl) 180:57–62CrossRefGoogle Scholar
  11. Del AA, Zhu S, Terasmaa A, Mohammed AH, Fuxe K (2004) Hyperactivity to novelty induced by social isolation is not correlated with changes in D2 receptor function and binding in striatum. Psychopharmacology (Berl) 171:148–155CrossRefGoogle Scholar
  12. Domeney A, Feldon J (1998) The disruption of prepulse inhibition by social isolation in the Wistar rat: how robust is the effect? Pharmacol Biochem Behav 59:883–890PubMedCrossRefGoogle Scholar
  13. Douglas LA, Varlinskaya EI, Spear LP (2003) Novel-object place conditioning in adolescent and adult male and female rats: effects of social isolation. Physiol Behav 80:317–325PubMedCrossRefGoogle Scholar
  14. Fabricius K, Helboe L, Fink-Jensen A, Wortwein G, Steiniger-Brach B, Sotty F (2010a) Increased dopaminergic activity in socially isolated rats: an electrophysiological study. Neurosci Lett 482:117–122PubMedCrossRefGoogle Scholar
  15. Fabricius K, Helboe L, Steiniger-Brach B, Fink-Jensen A, Pakkenberg B (2010b) Stereological brain volume changes in post-weaned socially isolated rats. Brain Res 1345:233–239PubMedCrossRefGoogle Scholar
  16. Fell MJ, Svensson KA, Johnson BG, Schoepp DD (2008) Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (−)-(1R, 4S, 5S, 6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4, 6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther 326:209–217PubMedCrossRefGoogle Scholar
  17. Fenton WS, Stover EL, Insel TR (2003) Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective. Psychopharmacology (Berl) 169:365–366CrossRefGoogle Scholar
  18. Fone KC, Porkess MV (2008) Behavioural and neurochemical effects of post-weaning social isolation in rodents—relevance to developmental neuropsychiatric disorders. Neurosci Biobehav Rev 32:1087–1102PubMedCrossRefGoogle Scholar
  19. Fulford AJ, Marsden CA (1998) Effect of isolation-rearing on conditioned dopamine release in vivo in the nucleus accumbens of the rat. J Neurochem 70:384–390PubMedCrossRefGoogle Scholar
  20. Geyer MA, Wilkinson LS, Humby T, Robbins TW (1993) Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 34:361–372PubMedCrossRefGoogle Scholar
  21. Green MF, Marder SR, Glynn SM, McGurk SR, Wirshing WC, Wirshing DA, Liberman RP, Mintz J (2002) The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biol Psychiatry 51:972–978PubMedCrossRefGoogle Scholar
  22. Hall FS, Huang S, Fong GW, Pert A, Linnoila M (1998) Effects of isolation-rearing on locomotion, anxiety and responses to ethanol in Fawn Hooded and Wistar rats. Psychopharmacology (Berl) 139:203–209CrossRefGoogle Scholar
  23. Heidbreder CA, Weiss IC, Domeney AM, Pryce C, Homberg J, Hedou G, Feldon J, Moran MC, Nelson P (2000) Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome. Neuroscience 100:749–768PubMedCrossRefGoogle Scholar
  24. Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ (1998) Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J Pharmacol Exp Ther 284:651–660PubMedGoogle Scholar
  25. Jones GH, Hernandez TD, Kendall DA, Marsden CA, Robbins TW (1992) Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry. Pharmacol Biochem Behav 43:17–35PubMedCrossRefGoogle Scholar
  26. Jones C, Brown A, Auer D, Fone K (2010) The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat. Psychopharmacology 1–15. doi: 10.1007/s00213-010-1931-7
  27. Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 157:514–520PubMedCrossRefGoogle Scholar
  28. Kapur S, Zipursky RB, Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156:286–293PubMedGoogle Scholar
  29. Krebs-Thomson K, Giracello D, Solis A, Geyer MA (2001) Post-weaning handling attenuates isolation-rearing induced disruptions of prepulse inhibition in rats. Behav Brain Res 120:221–224PubMedCrossRefGoogle Scholar
  30. McGrath J, Saha S, Chant D, Welham J (2008) Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30:67–76PubMedCrossRefGoogle Scholar
  31. Murphy BP, Chung YC, Park TW, McGorry PD (2006) Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophr Res 88:5–25PubMedCrossRefGoogle Scholar
  32. Nakato K, Morita T, Wanibuchi F, Yamaguchi T (1997) Antipsychotics restored but antidepressants and anxiolytics did not restore prepulse inhibition (PPI) deficits in isolation-reared rats. Soc Neurosci Abstr 23:1855Google Scholar
  33. Pearlson GD (2000) Neurobiology of schizophrenia. Ann Neurol 48:556–566PubMedCrossRefGoogle Scholar
  34. Powell SB, Geyer MA, Preece MA, Pitcher LK, Reynolds GP, Swerdlow NR (2003) Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats. Neuroscience 119:233–240PubMedCrossRefGoogle Scholar
  35. Robbins TW, Jones GH, Wilkinson LS (1996) Behavioural and neurochemical effects of early social deprivation in the rat. Journal of Psychopharmacology 10:39–47CrossRefGoogle Scholar
  36. Rorick-Kehn LM, Johnson BG, Burkey JL, Wright RA, Calligaro DO, Marek GJ, Nisenbaum ES, Catlow JT, Kingston AE, Giera DD, Herin MF, Monn JA, McKinzie DL, Schoepp DD (2007) Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (−)-(1R, 4S, 5S, 6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4, 6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther 321:308–317PubMedCrossRefGoogle Scholar
  37. Schaefer GJ, Michael RP (1984) Drug interactions on spontaneous locomotor activity in rats. Neuroleptics and amphetamine-induced hyperactivity. Neuropharmacology 23:909–914PubMedCrossRefGoogle Scholar
  38. Schlumberger C, Schafer D, Barberi C, More L, Nagel J, Pietraszek M, Schmidt WJ, Danysz W (2009) Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition. Behav Pharmacol 20:56–66PubMedCrossRefGoogle Scholar
  39. Schultz SH, North SW, Shields CG (2007) Schizophrenia: a review. Am Fam Physician 75:1821–1829PubMedGoogle Scholar
  40. Shigemi K, Tsuneyoshi Y, Yamada S, Kabuki Y, Hayamizu K, Denbow DM, Furuse M (2010) Oral administration of l-serine reduces the locomotor activity of socially isolated rats. Neurosci Lett 468:75–79PubMedCrossRefGoogle Scholar
  41. Swerdlow NR, Braff DL, Geyer MA (2000) Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11:185–204PubMedCrossRefGoogle Scholar
  42. Varty GB, Higgins GA (1995) Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology (Berl) 122:15–26CrossRefGoogle Scholar
  43. Wadenberg ML, Hicks PB (1999) The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics? Neurosci Biobehav Rev 23:851–862PubMedCrossRefGoogle Scholar
  44. Wadenberg ML, Ericson E, Magnusson O, Ahlenius S (1990) Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral, but not the dorsal, striatum of the rat. Biol Psychiatry 28:297–307PubMedCrossRefGoogle Scholar
  45. Wadenberg ML, Hicks PB, Richter JT, Young KA (1998) Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100, 907. Biol Psychiatry 44:508–515PubMedCrossRefGoogle Scholar
  46. Weiss IC, Feldon J (2001) Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology (Berl) 156:305–326CrossRefGoogle Scholar
  47. Weiss IC, Feldon J, Domeney AM (1999) Isolation rearing-induced disruption of prepulse inhibition: further evidence for fragility of the response. Behav Pharmacol 10:139–149PubMedCrossRefGoogle Scholar
  48. Weiss IC, Di IL, Feldon J, Domeney AM (2000) Strain differences in the isolation-induced effects on prepulse inhibition of the acoustic startle response and on locomotor activity. Behav Neurosci 114:364–373PubMedCrossRefGoogle Scholar
  49. Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer MA, Robbins TW (1994) Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology 10:61–72PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Katrine Fabricius
    • 1
    • 4
  • Lone Helboe
    • 2
  • Anders Fink-Jensen
    • 3
    • 4
  • Gitta Wörtwein
    • 3
    • 4
  • Björn Steiniger-Brach
    • 1
  1. 1.Department of Synaptic Transmission2H. Lundbeck A/S, Synaptic TransmissionValbyDenmark
  2. 2.Department of Neurodegeneration2H. Lundbeck A/S, NeurodegenerationValbyDenmark
  3. 3.Laboratory of Neuropsychiatry, Mental Health Services Copenhagen, The Capital Region of DenmarkUniversity of CopenhagenCopenhagenDenmark
  4. 4.Faculty of Health SciencesCopenhagenDenmark

Personalised recommendations